Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor
Aadilah Omar(University of the Witwatersrand), Stefan Weiß(University of the Witwatersrand), R. J. Caveney(University of the Witwatersrand), Katarina Jovanović(Inserm), Bianca Da Costa Dias(University of the Witwatersrand), Danielle Gonsalves(University of the Witwatersrand), Kiashanee Moodley(University of the Witwatersrand), Vusi Mbazima(University of the Witwatersrand)
Cited by 35
Related Papers
Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
|Frontiers in Oncology|2019|80
Anti-LRP/LR-Specific Antibody IgG1-iS18 Significantly Reduces Adhesion and Invasion of Metastatic Lung, Cervix, Colon and Prostate Cancer Cells
|Journal of Molecular Biology|2012|53
Cancer and HIV: The Molecular Mechanisms of the Deadly Duo
|Cancers|2024|48
Prion Interaction with the 37-kDa/67-kDa Laminin Receptor on Enterocytes as a Cellular Model for Intestinal Uptake of Prions
|Journal of Molecular Biology|2010|26